Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Kelun's TROP2 ADC plus Keytruda improves outcomes in first-line lung cancer
Merck’s partner on an experimental antibody-drug conjugate has reported a Phase 3 win in first-line lung cancer, and will take the data to Chinese regulatory authoritie...
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page